Guru Ownership Trend
Guru Analysis for Ligand Pharmaceuticals Incorporated (LGND)
Ligand Pharmaceuticals Incorporated (LGND), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 5 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $89.45 M.
Top institutional holders include Private Capital and Ken Fisher.
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $1.98 M net outflow during the quarter.
Recent activity highlights Jefferies Group who opened a new position. Conversely, Joel Greenblatt reduced exposure by 55.4%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Ligand Pharmaceuticals Incorporated (LGND)
Major holders include Private Capital ($40.21 M), Ken Fisher ($25.55 M), Cliff Asness ($1.48 M). According to the latest reported data, 5 tracked investment managers collectively hold approximately 348,299 shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $1.98 M, with 2 managers increasing positions and 4 managers reducing holdings.
During the most recent reporting period, 3 managers trimmed their positions, while 1 fully exited LGND. The total reported sell value was $3.9 M.
Yes, 1 managers opened new positions in LGND, and 1 increased their existing holdings. The total reported buy value was $1.92 M.